{"disease":{"id":"candida","name":"candida"},"drugs":{"marketed":[{"drug_id":"abrocitinib-200-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 200 mg","generic_name":"abrocitinib-200-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"JAK inhibitor","quality_score":40,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in children aged 12 years and older who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"abrocitinib-100-mg","indication_name":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrocitinib 100 mg","generic_name":"abrocitinib-100-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1","drug_class":"Janus kinase inhibitor","quality_score":48,"revenue":"284","mechanism":""},{"drug_id":"flucytosine","indication_name":"Serious Candida Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ancobon","generic_name":"FLUCYTOSINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Nucleoside Analog Antifungal [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"flucytosine","indication_name":"Candida Pulmonary Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ancobon","generic_name":"FLUCYTOSINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Nucleoside Analog Antifungal [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"posaconazole","indication_name":"Prophylaxis of Invasive Aspergillus and Candida Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"POSACONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"voriconazole","indication_name":"Deep Tissue Candida Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VORICONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"clotrimazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"caspofungin","indication_name":"Candida Peritonitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cancidas","generic_name":"CASPOFUNGIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Echinocandin Antifungal","quality_score":63,"revenue":null,"mechanism":"Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall."},{"drug_id":"caspofungin","indication_name":"Candida Pleural Space Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cancidas","generic_name":"CASPOFUNGIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Echinocandin Antifungal","quality_score":63,"revenue":null,"mechanism":"Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall."},{"drug_id":"caspofungin","indication_name":"Intra-Abdominal Candida Abscess","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cancidas","generic_name":"CASPOFUNGIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Echinocandin Antifungal","quality_score":63,"revenue":null,"mechanism":"Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall."},{"drug_id":"anidulafungin","indication_name":"Candida Peritonitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eraxis","generic_name":"ANIDULAFUNGIN","company_name":"Vicuron Holdings","drug_phase":"marketed","molecular_target":"","drug_class":"Echinocandin Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Eraxis works by inhibiting the synthesis of beta-1,3-D-glucan, a critical component of the fungal cell wall."},{"drug_id":"anidulafungin","indication_name":"Intra-Abdominal Candida Abscess","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eraxis","generic_name":"ANIDULAFUNGIN","company_name":"Vicuron Holdings","drug_phase":"marketed","molecular_target":"","drug_class":"Echinocandin Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Eraxis works by inhibiting the synthesis of beta-1,3-D-glucan, a critical component of the fungal cell wall."},{"drug_id":"sulfanilamide","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avc","generic_name":"SULFANILAMIDE","company_name":"Pharmobedient","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 13","drug_class":"sulfanilamide","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"micafungin","indication_name":"Candida Peritonitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycamine","generic_name":"MICAFUNGIN","company_name":"Teva Pharms Usa Inc","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Echinocandin Antifungal","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"micafungin","indication_name":"Candidal septicemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycamine","generic_name":"MICAFUNGIN","company_name":"Teva Pharms Usa Inc","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Echinocandin Antifungal","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Candida Peritonitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Candidal endocarditis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Candidal meningitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Candidal septicemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"gentian-violet","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methylrosaniline Chloride","generic_name":"GENTIAN VIOLET","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"nystatin","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycostatin","generic_name":"nystatin","company_name":"Generic (originally Squibb)","drug_phase":"marketed","molecular_target":"Ergosterol (fungal cell membrane)","drug_class":"Polyene Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"butoconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femstat 3","generic_name":"BUTOCONAZOLE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"aldactone","indication_name":"Long-term maintenance therapy for discrete aldosterone-producing adrenal adenomas in non-surgical candidates","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"Spironolactone","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldosterone receptors at aldosterone-dependent sodium-potassium exchange site in distal convoluted renal tubule","drug_class":"Potassium-sparing diuretic, aldosterone antagonist","quality_score":66,"revenue":null,"mechanism":"Aldosterone antagonist causing increased sodium and water excretion while retaining potassium."},{"drug_id":"fluconazole","indication_name":"Candidal Urinary Tract Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Candidal septicemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"omoconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OMOCONAZOLE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"omoconazole","quality_score":null,"revenue":null,"mechanism":"Omoconazole works by inhibiting the growth of fungal cells."},{"drug_id":"fluconazol","indication_name":"Candidal Urinary Tract Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluconazol","company_name":"Azienda Sanitaria-Universitaria Integrata di Udine","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluconazol","indication_name":"Candidal septicemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluconazol","company_name":"Azienda Sanitaria-Universitaria Integrata di Udine","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluconazol","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluconazol","company_name":"Azienda Sanitaria-Universitaria Integrata di Udine","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"miconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fenticonazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lomexin","generic_name":"FENTICONAZOLE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"fenticonazole","quality_score":null,"revenue":null,"mechanism":"Lomexin works by inhibiting the growth of fungi through interference with the synthesis of ergosterol, a critical component of fungal cell membranes."},{"drug_id":"flucytosine","indication_name":"Candidal Urinary Tract Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ancobon","generic_name":"FLUCYTOSINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Nucleoside Analog Antifungal [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Candida urinary tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"flucytosine","indication_name":"Synergy for Candida Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ancobon","generic_name":"FLUCYTOSINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Nucleoside Analog Antifungal [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Candida peritonitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Systemic Candida infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":38,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06420479","title":"The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06433700","title":"Risk of Revision Following Knee Arthroplasty in Bariatric Surgery Patients","phase":"","overall_status":"COMPLETED","enrollment_count":99965,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT03955952","title":"Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":13722,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT05532891","title":"Bariatric Surgery and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":11545,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT04136704","title":"Long-Term Outcomes of LSG in Pediatric Patients","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT04494048","title":"Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05215886","title":"Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":9500,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03556995","title":"Suggesting Score Scale for Risk of Bleeding in Bariatric Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":9044,"lead_sponsor_name":"Assuta Medical Center","has_results":false},{"nct_id":"NCT06226194","title":"Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":6966,"lead_sponsor_name":"Institut de Recerca Biomèdica de Lleida","has_results":false},{"nct_id":"NCT05725967","title":"Endoscopic Metabolic and Bariatric Therapies","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Christopher C. Thompson, MD, MSc","has_results":false},{"nct_id":"NCT06464822","title":"Prospective Data on Bariatric Surgery Effect on IPSS and LUTS","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06510452","title":"Antibiotic Prophylaxis in Metabolic Bariatric Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3352,"lead_sponsor_name":"General Committee of Teaching Hospitals and Institutes, Egypt","has_results":false},{"nct_id":"NCT05724992","title":"Familial Pancreatic Cancer PROPHilation Program in Italy","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Associazione Italiana per lo Studio del Pancreas","has_results":false},{"nct_id":"NCT06372912","title":"Early Postoperative Complications in Patients Undergoing Bariatric Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Instituto Mexicano del Seguro Social","has_results":false},{"nct_id":"NCT06908980","title":"CHOLE-POSSUM PRO Validation for Prediction of Mortality After Cholecystectomy for Acute Calculous Cholecystitis: Protocol for a Prospective Multicenter Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT06324526","title":"Obesity and Health-related Quality of Life in Patients Receiving Bariatric Surgery in the UK","phase":"","overall_status":"COMPLETED","enrollment_count":2160,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT05575947","title":"Comparative Analysis of da Vinci-Assisted and Laparoscopic Duodenal Switch Bariatric Surgical Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":1878,"lead_sponsor_name":"Intuitive Surgical","has_results":false},{"nct_id":"NCT04329780","title":"Retrospective Comparison of Lap and Robotic-Assisted RYGB and SG","phase":"","overall_status":"COMPLETED","enrollment_count":1872,"lead_sponsor_name":"Intuitive Surgical","has_results":false},{"nct_id":"NCT04480034","title":"Obesity Surgery During 2020 Italian Pandemic","phase":"","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"University of Roma La Sapienza","has_results":false},{"nct_id":"NCT04174495","title":"Bone Fragility Evaluation in Obese Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06592313","title":"Difficult Airway in the Bariatric Patient: The BARINTUBE Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":1290,"lead_sponsor_name":": Manuel Alberto Guerrero Gutierrez","has_results":false},{"nct_id":"NCT05140798","title":"Abu Dhabi Diabetes and Obesity Study -2 Bariatric","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Imperial College London Diabetes Centre","has_results":false},{"nct_id":"NCT05987631","title":"Predictors of Weight Loss and Metabolic Health After Bariatric Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT06338423","title":"Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure","phase":"NA","overall_status":"COMPLETED","enrollment_count":1184,"lead_sponsor_name":"Jagiellonian University","has_results":false},{"nct_id":"NCT03599323","title":"Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)","phase":"","overall_status":"COMPLETED","enrollment_count":1033,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05743166","title":"Bariatric Surgery Observation Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"St. Olavs Hospital","has_results":false},{"nct_id":"NCT03762590","title":"GENetic Education Risk Assessment and TEsting Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06975436","title":"Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis","phase":"","overall_status":"COMPLETED","enrollment_count":738,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04935463","title":"Mucormycosis in COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":728,"lead_sponsor_name":"Montefiore Medical Center","has_results":false},{"nct_id":"NCT04575987","title":"Long Term Effect of Bariatric Surgery on Pelvic Floor Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":709,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT03489538","title":"Homocysteine After Laparoscopic Roux-enY Gastric Bypass","phase":"","overall_status":"COMPLETED","enrollment_count":708,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04944810","title":"Magnetic System in Bariatric and General Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Unidad Internacional de Cirugia Bariatrica y Metabolica","has_results":false},{"nct_id":"NCT06131749","title":"Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa","phase":"","overall_status":"COMPLETED","enrollment_count":603,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT02169518","title":"Paraoxonase and HDL Qualities in Glycaemia and Inflammation","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT06056947","title":"Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":577,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT01431430","title":"VITamine D Supplementation in RenAL Transplant Recipients - VITALE","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":538,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05291741","title":"Use of Very Low Calorie Diet Preoperatively to Bariatric Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT05194943","title":"Trends and Safety in Revisional Bariatric Surgery in Italy","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Roma La Sapienza","has_results":false},{"nct_id":"NCT04945304","title":"9-Step Magnetic Bariatric Revisional Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Unidad Internacional de Cirugia Bariatrica y Metabolica","has_results":false},{"nct_id":"NCT03766932","title":"Antigenic and Antibody Detection of Candida","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06346145","title":"Impact of Bariatric Surgery on Heart Disease Compared to Standard Care","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Danderyd Hospital","has_results":false},{"nct_id":"NCT03864861","title":"Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol","phase":"","overall_status":"UNKNOWN","enrollment_count":460,"lead_sponsor_name":"Grupo Español de Rehabilitación Multimodal","has_results":false},{"nct_id":"NCT03987620","title":"Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":455,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT06207357","title":"Optical Trocar to Create the Pneumoperitoneum in Bariatric Patients","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"University of Foggia","has_results":false},{"nct_id":"NCT04179188","title":"Impact of Bariatric Surgery in Obese Patients With and Without Obstructive Sleep Apnea Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Ramsay Générale de Santé","has_results":false},{"nct_id":"NCT06198790","title":"Postoperative Anemia After Bariatric Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT06287931","title":"Probiotics for Gallstones in Post-bariatric Surgery Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Shandong Linglong Yingcheng Hospital","has_results":false},{"nct_id":"NCT04851470","title":"Periodontal Assessment of a Bariatric Care Population","phase":"","overall_status":"RECRUITING","enrollment_count":394,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT05009290","title":"A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":391,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT03734991","title":"Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Scynexis, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}